Summary of Purpose
Agents of sanchi have been widely used as a complementary medicine for stroke in China. Sanchitongshu is a new Chinese patent medicine extracted from sanchi which has stronger anti-platelet activity than other agents of sanchi. The investigators's aim was to investigate the synergistic action of aspirin combined with sanchitongshu capsule in the treatment of patients with minor ischemic stroke and transient...Read More →
The following dates are available for this trial. Trial information last updated on 22 November 2016.
|1 Dec 2016||18 Nov 2016||1 Nov 2019||1 Nov 2019||1 Nov 2016||Unavailable|
|Start Date||First Received||1st Completion||Completion||Verification||Results|
Interventions See All